1. Diagnosis and treatment of alcoholism

   Newsletter Article 12 February 2013 Pages: 2 - 3

2. Prophylactic measures for suxamethonium myalgia

   Newsletter Article 12 February 2013 Pages: 3 - 3

3. Current treatment of chemical dependence

   Newsletter Article 12 February 2013 Pages: 3 - 3

4. Postmarketing surveillance of aciclovir

   Newsletter Article 12 February 2013 Pages: 3 - 4

5. Manifestations of cocaine abuse

   Newsletter Article 12 February 2013 Pages: 4 - 4

6. Alteplase

   Newsletter Article 12 February 2013 Pages: 5 - 5

7. Amiodarone

   Newsletter Article 12 February 2013 Pages: 5 - 5

8. Amitriptyline overdose

   Newsletter Article 12 February 2013 Pages: 5 - 5

9. Anticoagulants

   Newsletter Article 12 February 2013 Pages: 5 - 5

10. Baclofen

    Newsletter Article 12 February 2013 Pages: 5 - 5

11. Buspirone

    Newsletter Article 12 February 2013 Pages: 5 - 5

12. Busulfan

    Newsletter Article 12 February 2013 Pages: 6 - 6

13. Carbamazepine

    Newsletter Article 12 February 2013 Pages: 6 - 6

14. Carbamazepine interactions

    Newsletter Article 12 February 2013 Pages: 6 - 6

15. Carmofur

    Newsletter Article 12 February 2013 Pages: 6 - 6

16. Cefotaxime

    Newsletter Article 12 February 2013 Pages: 6 - 6

17. Ceftriaxone

    Newsletter Article 12 February 2013 Pages: 6 - 6

18. Charcoal

    Newsletter Article 12 February 2013 Pages: 6 - 6

19. Chlorpropamide

    Newsletter Article 12 February 2013 Pages: 6 - 7

20. Cimetidine see Suxamethonium interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

21. Clothiapine/perphenazine

    Newsletter Article 12 February 2013 Pages: 7 - 7

22. Cyclosporin

    Newsletter Article 12 February 2013 Pages: 7 - 7

23. Diclofenac see Lithium interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

24. Diltiazem interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

25. Erythromycin see Theophylline

    Newsletter Article 12 February 2013 Pages: 7 - 7

26. Etoposide

    Newsletter Article 12 February 2013 Pages: 7 - 7

27. Fluoride poisoning

    Newsletter Article 12 February 2013 Pages: 7 - 7

28. Heparin/warfarin

    Newsletter Article 12 February 2013 Pages: 7 - 7

29. Homatropine

    Newsletter Article 12 February 2013 Pages: 7 - 8

30. Interferon alpha 2A

    Newsletter Article 12 February 2013 Pages: 8 - 8

31. Isoprenaline

    Newsletter Article 12 February 2013 Pages: 8 - 8

32. Lead poisoning

    Newsletter Article 12 February 2013 Pages: 8 - 8

33. Lithium see Diltiazem interaction

    Newsletter Article 12 February 2013 Pages: 8 - 8

34. Lithium interaction

    Newsletter Article 12 February 2013 Pages: 8 - 9

35. Medroxyprogesterone

    Newsletter Article 12 February 2013 Pages: 10 - 10

36. Methyldopa

    Newsletter Article 12 February 2013 Pages: 10 - 10

37. Perphenazine see Clothiazine/perphenazine

    Newsletter Article 12 February 2013 Pages: 10 - 10

38. Phenylephrine

    Newsletter Article 12 February 2013 Pages: 10 - 10

39. Phenytoin

    Newsletter Article 12 February 2013 Pages: 10 - 10

40. Prednisolone

    Newsletter Article 12 February 2013 Pages: 10 - 10

41. Prednisone

    Newsletter Article 12 February 2013 Pages: 10 - 10

42. Propafenone

    Newsletter Article 12 February 2013 Pages: 10 - 10

43. Sotalol

    Newsletter Article 12 February 2013 Pages: 10 - 11

44. Streptokinase/heparin

    Newsletter Article 12 February 2013 Pages: 11 - 11

45. Suxamethonium interaction

    Newsletter Article 12 February 2013 Pages: 11 - 11

46. Thioridazine overdose

    Newsletter Article 12 February 2013 Pages: 11 - 11

47. Vincristine

    Newsletter Article 12 February 2013 Pages: 11 - 12

48. Warfarin see Heparin/warfarin

    Newsletter Article 12 February 2013 Pages: 12 - 12

49. Dysmorphogenesis:

    Newsletter Article 12 February 2013 Pages: 12 - 12